Asahi Kasei Pharma’s Apr-Sep Sales Up 6% Due to Doubled Recomodulin Sales

November 4, 2011
Asahi Kasei Pharma reported on November 2 an increase in the non-consolidated sales for April to September to ¥29.8 billion (+6.0% compared to the corresponding period of the previous year). The favorable sales were mainly due to the doubled increase...read more